Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
01/2011
01/27/2011CA2768980A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders
01/27/2011CA2768832A1 Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators
01/27/2011CA2767088A1 Inhibitors of flaviviridae viruses
01/26/2011EP2277879A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
01/26/2011EP2277869A1 Cycloalkylamidbenzoxa(thia)zoles as fungicides
01/26/2011EP2277867A2 Compounds, pharmaceutical compositions thereof and their use in treating cancer
01/26/2011EP2277865A1 Phenyl-substituted 6-ring nitrogen-heterocycles as microtubule polymerisation inhibitors
01/26/2011EP2277862A2 5-hydroxy-4-aminomethyl-1-cyclohexane or (cycloheptyl)--3-alkoxycarbonyl indole derivatives, pharmaceutically acceptable antiviral salts thereof and a method for the production thereof
01/26/2011EP2276761A1 Carboxamide compounds for the treatment of metabolic disorders
01/26/2011EP2276758A1 Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl]-3-nit robenzene-1, 2-diol
01/26/2011EP2276747A1 Sulfonamides as zap-70 inhibitors
01/26/2011EP2276746A1 Substituted pyridazinylmethyl sulfonamides
01/26/2011EP2276738A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
01/26/2011EP2276737A1 4- [3- (aryloxy) benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
01/26/2011EP2276736A1 4- [3- (aryloxy) benzyliden]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
01/26/2011EP2276735A1 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
01/26/2011EP2276734A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
01/26/2011EP2276732A1 Novel estrogen receptor ligands
01/26/2011EP2049514B1 Nitrate esters of piperidines
01/26/2011EP2041125B1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds
01/26/2011EP2019825B9 Inhibitors of human immunodeficiency virus replication
01/26/2011EP1973888B1 Isoxazolines for controlling invertebrate pests
01/26/2011EP1948616B1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
01/26/2011EP1904489B1 Process for the synthesis of triazoles
01/26/2011EP1853596B1 Novel, long-acting betamimetics for treating respiratory diseases
01/26/2011EP1831173B1 Tetrahydroisoquinoline compounds for treatment of cns disorders
01/26/2011CN101959882A 咪唑羰基化合物 Imidazole-carbonyl compound
01/26/2011CN101959881A 5-O-substituted 3-N-phenyl-1,3,4-oxadiazolones for medical use
01/26/2011CN101440090B 2-(6'-imine pyridinyl) benzoxazole metal complexes, as well as preparation method and application thereof
01/25/2011US7875748 Prepared by reaction of tetraphenylcyclopentadienone with 1,4-diethynyl-2,5-dimethoxybenzene; can be used as a core material for an organic electroluminescence element or other optical devices
01/25/2011US7875728 Hydrazonopyrazole derivatives and their use as therapeutics
01/25/2011US7875637 Benzimidazole derivative and use as a II receptor antagonist
01/25/2011US7875633 Phenylpyridone derivative
01/25/2011US7875619 Hetero substituted sodium channel blockers
01/25/2011US7875606 Izoxazoline derivative and herbicide
01/25/2011US7875605 1-Benzenesulfonyl-3-(4-methylpiperazin-1-ylmethyl)-5-nitro-1 H-indole; 1-[[5-Bromo-1-(2-Bromo-4-methoxybenzenesulfonyl)-indo1-3-yl]methyl][1,4]diazepane; useful for treating psychotic and neurodegenerative disorders e.g. schizophrenia, Alzheimer's disease, Parkinson's disease and Huntington's chorea
01/25/2011US7875600 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide
01/25/2011US7875261 Staining; for detecting reactive oxygen species such as hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays
01/25/2011CA2612287C Substituted arylpyrazoles for use against parasites
01/25/2011CA2467575C N-heteroarylnicotinamide derivatives
01/25/2011CA2410345C Substituted pyridine herbicides
01/25/2011CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives
01/25/2011CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
01/20/2011WO2011008709A1 Apoptosis signal-regulating kinase inhibitors
01/20/2011WO2011008560A1 Emissive aryl-heteroaryl compounds
01/20/2011WO2011007819A1 Pharmaceutical product containing lactam or benzene sulfonamide compound
01/20/2011WO2011007324A1 Pyridin-4-yl derivatives
01/20/2011WO2011006935A2 Tetrazole derivatives
01/20/2011WO2011006567A1 Aminopyridine derivatives for treating tumors and inflammatory diseases
01/20/2011US20110015371 Inhibitors of interleukin-1 beta converting enzyme
01/20/2011US20110015241 Substituted heterocycles and use thereof
01/20/2011US20110015234 Indazole derivatives
01/20/2011US20110015231 Isoxazole and isothiazole compounds useful in the treatment of inflammation
01/20/2011US20110015203 Viral Polymerase Inhibitors
01/20/2011US20110015194 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
01/20/2011US20110015193 1, 5-dihydro-pyrazolo (3, 4-d) pyrimidin-4-one derivatives and their use as pde9a mudulators for the treatment of cns disorders
01/20/2011US20110015192 Sirtuin modulating compounds
01/20/2011US20110015191 Organic compounds
01/20/2011US20110015185 Benzofuran Compounds
01/20/2011US20110015181 Alkylaminopyridine derivative
01/20/2011US20110015180 Chemokine receptor antagonists
01/20/2011US20110015178 Amido-Thiophene Compounds and Their Use
01/20/2011US20110015157 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
01/20/2011US20110015156 Heterocyclic compounds for the treatment of neurological and psychological disorders
01/20/2011US20110015137 Reca inhibitors and their uses as microbial inhibitors or potentiators of antibiotic activity
01/20/2011US20110014599 Novel Fluorescent Dyes and Uses Thereof
01/20/2011US20110014121 Modulators of cxcr7
01/20/2011CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases
01/20/2011CA2767894A1 Apoptosis signal-regulating kinase inhibitors
01/20/2011CA2767887A1 Benzimidazole analogues for the treatment or prevention of flavivirus infections
01/20/2011CA2767585A1 Pyridin-4-yl derivatives
01/20/2011CA2766874A1 Tetrazole derivatives
01/19/2011EP2275105A1 Heterocyclic derivatives as opioid receptor modulators
01/19/2011EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors
01/19/2011EP2274983A1 Harmful arthropod control composition, and fused heterocyclic compound
01/19/2011EP2274305A2 2-[(1h-pyrazole-4-ylmethyl)-sulfonyl]-oxazole derivatives, 2-[(1h-pyrazole-4-ylmethyl)-sulfanyl]-oxazole derivatives, and chiral 2-[(1h-pyrazole-4-ylmethyl)-sulfinyl]-oxazole derivatives, methods for the production thereof, and use thereof as herbicides and plant growth regulators
01/19/2011EP2274304A1 Method of treating cancer using a cmet and axl inhibitor and an erbb inhibitor
01/19/2011EP2274299A1 Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases
01/19/2011EP2274297A1 Pyrrolidinone glucokinase activators
01/19/2011EP2274296A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
01/19/2011EP2274295A1 3, 4 - substituted piperidine derivatives as renin inhibitors
01/19/2011EP2274288A2 Macrocyclic compounds and their use as kinase inhibitors
01/19/2011EP2274287A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
01/19/2011EP2274282A1 Compounds for use in stabilizing p53 mutants
01/19/2011EP2273992A1 Quenolines and related analogs as sirtuin modulators
01/19/2011EP1945634B1 Phenylenebisoxazolidine derivatives and their use as anticoagulants
01/19/2011EP1919899B1 Macrocyclic inhibitors of hepatitis c virus
01/19/2011EP1581509B1 1-(amino)indanes as edg receptor agonists
01/19/2011EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
01/19/2011EP1330442B1 Phthalazinone derivatives
01/19/2011CN101952280A Bicyclic heterocyclic derivative
01/19/2011CN101952275A Modulators for amyloid beta
01/19/2011CN101952260A 4, 5-dihydro-oxazol-2-yl amine derivatives
01/19/2011CN101952259A Benzodiazepine compound and pharmaceutical composition
01/19/2011CN101952247A Intermediate compounds for the preparation of meso-substituted cyanine, merocyanine and oxonole dyes
01/19/2011CN101951904A Benzothiazole and benzoxazole derivatives and methods of use
01/19/2011CN101948475A Isoflavone derivate-chromene (chroman) oxazines compound, preparation method and application thereof
01/19/2011CN101948464A 3,4,6-triaryl-(1,3)-oxazine-2-ketone compound as well as preparation method and application thereof
01/19/2011CN101948462A Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity
01/19/2011CN101948458A Baicalein derivatives with antitumor activity and application thereof in medicines